Giuseppe Gentile | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Efficacy and safety of BNT162b2 mRNA vaccine in a cohort of 90 transfusion dependent thalassemia patients	TRANSFUSION MEDICINE	2024
Molecular monitoring of viral infections in immunocompromised patients in a large university hospital in Italy: reflections after thirteen years of real-life activity	EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES	2024
Ttv and cmv viral load dynamics. Which emerges first during immunosuppression	JOURNAL OF MEDICAL VIROLOGY	2024
Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-Producing Klebsiella pneumoniae for Febrile Neutropenic Episodes in Colonized Children with Acute Leukemia—An 8-Year Retrospective Observational Study	ANTIBIOTICS	2024
Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-K. pneumoniae in Febrile Neutropenic Patients with Acute Leukemia Who are Colonized with KPC-K. pneumoniae. A 7-Years Retrospective Observational Cohort Study	INFECTION AND DRUG RESISTANCE	2023
Case Report: Infectious prophylaxis in hematological malignancies	FRONTIERS IN ONCOLOGY	2023
Multiplicity of blaKPC genes and pKpQIL plasmid plasticity in the development of ceftazidime-avibactam and Meropenem coresistance in Klebsiella pneumoniae sequence type 307	ANTIMICROBIAL AGENTS AND CHEMOTHERAPY	2023
Editorial: HBV and lymphoma	FRONTIERS IN ONCOLOGY	2023
High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy	ANNALS OF HEMATOLOGY	2023
Impact of Sars-CoV-2 Prophylaxis with Tixagevimab-Cilgavimab in High-Risk Patients with B-Cell Malignancies: A Single-Center Retrospective Study	MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES	2023
Impact of anti-SARS-CoV-2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective study	HEMATOLOGICAL ONCOLOGY	2022
Covid-19 vaccination in patients with immune-mediated thrombotic thrombocytopenic purpura: a single-referral center experience	HAEMATOLOGICA	2022
Impact of Anti-Sars-Cov-2 Monoclonal Antibodies in the Management of Patients with Lymphoma and COVID19: A Retrospective Study	BLOOD	2022
Response to the conjugate pneumococcal vaccine (PCV13) in patients with chronic lymphocytic leukemia (CLL)	LEUKEMIA	2021
Correspondence in reference to the previously published Epub manuscript: “Murt Ahmet et al. Hepatitis B reactivation in hematopoietic stem cell transplanted patients: 20 years of experience of a single center from a middle endemic country. Annals of Hematology 2020; 99: 2671-2677”	ANNALS OF HEMATOLOGY	2021
Regarding “Hepatitis B Surface Antigen Positivity Is an Independent Unfavorable Prognostic Factor in Diffuse Large B-Cell Lymphoma in the Rituximab Era”	THE ONCOLOGIST	2021
Reduced mortality from KPC-K.pneumoniae bloodstream infection in high-risk patients with hematological malignancies colonized by KPC-K.pneumoniae	BMC INFECTIOUS DISEASES	2021
Severe rituximab-induced pneumonitis in an immunocompromised child with acquired thrombotic thrombocytopenic purpura	PEDIATRIC BLOOD & CANCER	2021
Reduced transmission of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP) in patients with haematological malignancies hospitalized in an Italian hospital during the COVID-19 pandemic	JAC-ANTIMICROBIAL RESISTANCE	2021
Prognostic impact and risk factors of infections in patients with chronic lymphocytic leukemia treated with ibrutinib	CANCERS	2021